Mohsen Danaeifar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mohsen Danaeifar has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Babak Negahdari
Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
1 shared publicationHamed Zare
Pharmaceutical Sciences and Cosmetic Products Research Center, Kerman University of Medical Sciences, Kerman, Iran
1 shared publicationHoura Mobaleghol Eslam
Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
1 shared publicationMohsen Danaeifar
Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
1 shared publicationMomeneh Ghanaat
Department of Microbiology, Ayatollah Amoli Branch, Islamic Azad University, Amol, Iran
1 shared publicationSekinehe Shokouhi Koushali
Pharmaceutical Sciences and Cosmetic Products Research Center, Kerman University of Medical Sciences, Kerman, Iran
1 shared publication
Latest Publications
- 6 August 2024
- Published by Pleiades Publishing Ltd in Cell and Tissue Biology
- Vol. 18 (4) , 380-389
A Multi-Omics Analysis to Investigate the Co-Occurrence of Psoriasis and Crohn’s Diseases
Psoriasis is a chronic autoimmune condition that causes rapid buildup of skin cells. Crohn’s disease is a chronic inflammatory bowel disease that affects the gastrointestinal tract. Psoriasis and Crohn’s disease are both chronic inflammatory disorders that are believed to share some common genetic and environmental risk factors. Aim of this study is to investigate possible link between psoriasis and Crohn’s disease through multi-omics approach. To obtain transcriptomics data of psoriasis and Crohn’s disease, four and three datasets of gene expression omnibus (GEO), as well as two proteomics datasets for each disease were used. Gene expression analysis, protein-protein network analysis and pathway enrichment were performed for differentially expressed genes and proteins. The main enriched pathway in psoriasis is interleukin-27-mediated signaling pathway, while for Crohn’s disease it was tryptophan catabolic process to kynurenine. The results showed that coding genes of IL-8, IL-10 and IL-17A are the main link between psoriasis and Crohn’s disease and in this link, Th1 plays an important role. On the other hand, it was also shown that METTL7A facilitates the infiltration of Th1 cells into the skin and colon tissue. Through this study, important molecules that involved in co-occurrence of the psoriasis and Crohn’s disease are introduced.
- 6 August 2024
- Published by Pleiades Publishing Ltd in Cell and Tissue Biology
- Vol. 18 (4) , 380-389
A Multi-Omics Analysis to Investigate the Co-Occurrence of Psoriasis and Crohn’s Diseases
Psoriasis is a chronic autoimmune condition that causes rapid buildup of skin cells. Crohn’s disease is a chronic inflammatory bowel disease that affects the gastrointestinal tract. Psoriasis and Crohn’s disease are both chronic inflammatory disorders that are believed to share some common genetic and environmental risk factors. Aim of this study is to investigate possible link between psoriasis and Crohn’s disease through multi-omics approach. To obtain transcriptomics data of psoriasis and Crohn’s disease, four and three datasets of gene expression omnibus (GEO), as well as two proteomics datasets for each disease were used. Gene expression analysis, protein-protein network analysis and pathway enrichment were performed for differentially expressed genes and proteins. The main enriched pathway in psoriasis is interleukin-27-mediated signaling pathway, while for Crohn’s disease it was tryptophan catabolic process to kynurenine. The results showed that coding genes of IL-8, IL-10 and IL-17A are the main link between psoriasis and Crohn’s disease and in this link, Th1 plays an important role. On the other hand, it was also shown that METTL7A facilitates the infiltration of Th1 cells into the skin and colon tissue. Through this study, important molecules that involved in co-occurrence of the psoriasis and Crohn’s disease are introduced.
- 19 June 2023
- Published by Springer Nature in Biotechnology Letters
- Vol. 45 (9) , 1053-1072
Polymeric nanoparticles for DNA vaccine-based cancer immunotherapy: a review
Cancer is one of the leading causes of death and mortality in the world. There is an essential need to develop new drugs or therapeutic approaches to manage treatment-resistant cancers. Cancer immunotherapy is a type of cancer treatment that uses the power of the body’s immune system to prevent, control, and eliminate cancer. One of the materials used as a vaccine in immunotherapy is DNA. The application of polymeric nanoparticles as carriers for DNA vaccines could be an effective therapeutic approach to activate immune responses and increase antigen presentation efficiency. Various materials have been used as polymeric nanoparticles, including: chitosan, poly (lactic-co-glycolic acid), Polyethylenimine, dendrimers, polypeptides, and polyesters. Application of these polymer nanoparticles has several advantages, including increased vaccine delivery, enhanced antigen presentation, adjuvant effects, and more sustainable induction of the immune system. Besides many clinical trials and commercial products that were developed based on polymer nanoparticles, there is still a need for more comprehensive studies to increase the DNA vaccine efficiency in cancer immunotherapy using this type of carrier.
- 19 June 2023
- Published by Springer Nature in Biotechnology Letters
- Vol. 45 (9) , 1053-1072
Polymeric nanoparticles for DNA vaccine-based cancer immunotherapy: a review
Cancer is one of the leading causes of death and mortality in the world. There is an essential need to develop new drugs or therapeutic approaches to manage treatment-resistant cancers. Cancer immunotherapy is a type of cancer treatment that uses the power of the body’s immune system to prevent, control, and eliminate cancer. One of the materials used as a vaccine in immunotherapy is DNA. The application of polymeric nanoparticles as carriers for DNA vaccines could be an effective therapeutic approach to activate immune responses and increase antigen presentation efficiency. Various materials have been used as polymeric nanoparticles, including: chitosan, poly (lactic-co-glycolic acid), Polyethylenimine, dendrimers, polypeptides, and polyesters. Application of these polymer nanoparticles has several advantages, including increased vaccine delivery, enhanced antigen presentation, adjuvant effects, and more sustainable induction of the immune system. Besides many clinical trials and commercial products that were developed based on polymer nanoparticles, there is still a need for more comprehensive studies to increase the DNA vaccine efficiency in cancer immunotherapy using this type of carrier.
- 31 December 2022
- Vol. 77 (6) , 2181-2186
A Non-Structural Protein of Severe Acute Respiratory Syndrome Coronavirus 2 with a Potential Ability to Reduce Blood Glucose for Use in Controlling Type 2 Diabetes Mellitus
It is estimated that more than 400 million people worldwide are suffering from diabetes. There are two types of diabetes. Type 1 diabetes is the result of insufficient insulin secretion into the bloodstream, most often due to an autoimmune attack on the pancreas glands. Type 2 diabetes is caused by the inability of the surface ligands to adsorb the insulin from the bloodstream. The conventional medicines for diabetes mellitus include sulfonylureas, biguanide, thiazolidinediones, alpha-glucosidase inhibitors, and meglitinide. By February 2022, Severe acute respiratory syndrome coronavirus 2 (SARSCoV2) had infected more than 391 million people worldwide, claiming 5.7 million lives and imposing heavy costs on the healthcare system. The present study aimed to assess the potential use of this non-structural SARS-CoV-2 protein in the treatment of type 2 diabetes mellitus. The nsp10 was structurally aligned with GoDrugBank therapeutic agents, and lixisenatide was found to have the most similar chemical structure. This drug is a glucagon-like peptide-1 (GLP1) receptor agonist used for the treatment of type 2 diabetes mellitus. The best molecular docking energy score for these two proteins was -301.47, and the ligand root mean square deviation was calculated to be 107.93 Å. The molecular dynamics for the stability of the nsp10 and GLP1R binding in triplicate for 150 ns demonstrated that the nsp10-GLP1R remained bound for more than 80 ns. This study indicated that the nsp10 protein can be further studied to be used as an antidiabetic medication.
- 31 December 2022
- Vol. 77 (6) , 2181-2186
A Non-Structural Protein of Severe Acute Respiratory Syndrome Coronavirus 2 with a Potential Ability to Reduce Blood Glucose for Use in Controlling Type 2 Diabetes Mellitus
It is estimated that more than 400 million people worldwide are suffering from diabetes. There are two types of diabetes. Type 1 diabetes is the result of insufficient insulin secretion into the bloodstream, most often due to an autoimmune attack on the pancreas glands. Type 2 diabetes is caused by the inability of the surface ligands to adsorb the insulin from the bloodstream. The conventional medicines for diabetes mellitus include sulfonylureas, biguanide, thiazolidinediones, alpha-glucosidase inhibitors, and meglitinide. By February 2022, Severe acute respiratory syndrome coronavirus 2 (SARSCoV2) had infected more than 391 million people worldwide, claiming 5.7 million lives and imposing heavy costs on the healthcare system. The present study aimed to assess the potential use of this non-structural SARS-CoV-2 protein in the treatment of type 2 diabetes mellitus. The nsp10 was structurally aligned with GoDrugBank therapeutic agents, and lixisenatide was found to have the most similar chemical structure. This drug is a glucagon-like peptide-1 (GLP1) receptor agonist used for the treatment of type 2 diabetes mellitus. The best molecular docking energy score for these two proteins was -301.47, and the ligand root mean square deviation was calculated to be 107.93 Å. The molecular dynamics for the stability of the nsp10 and GLP1R binding in triplicate for 150 ns demonstrated that the nsp10-GLP1R remained bound for more than 80 ns. This study indicated that the nsp10 protein can be further studied to be used as an antidiabetic medication.
- 5 November 2022
- Published by Maad Rayan Publishing Company in Avicenna Journal of Medical Biochemistry
- Vol. 10 (2) , 148-152
A Flippase-Like Domain-Containing Protein From Deltaproteobacteria Bacterium (Marine Sediment Metagenome) Has Anti-prostate Cancer Effects
Background: Prostate cancer is the second prevalent cancer and the fifth cause of deaths related to the men malignancies. The cancerous cell can travel from prostate to other parts of the body and cause metastasis in other organs such as bones and lymph nodes. For the treatment of the prostate cancer, chemotherapy and hormone therapy are being used. Hormone therapy in this disease is primarily based on the androgen suppression to prevent the growth and division of the cancerous cells. Different classes of drugs are used for hormone therapy. One group of these drugs is reducers of androgen production in adrenal glands. These drugs prevent the androgen production in adrenal glands and cancerous cells. Leuprorelin which is also known as leuprolide is a synthetic peptide that is used for treatment of prostate cancer. Objectives: The aim of this study is to explore novel anti-prostate cancer compounds using proteomics of microorganisms. Methods: Leuprorelin synthetic peptide was chosen as the template for amino acid sequence homology search using blast, and the resulting protein of the best candidate sequences were employed as a query to perform docking test against the gonadotropin-releasing hormone receptor (GRHR) using HDOCK web server. Results: By employing an in silico approach, natural products with structure and function similar to leuprorelin were explored, and their features were characterized. A flippase-like domain-containing protein from Deltaproteobacteria bacterium showed strong binding to gonadotropin-releasing hormone receptor GRHR with docking score of -425. The absorption, distribution, metabolism, and excretion (ADME) tests showed no potential toxicity of this natural product to the body. Conclusion: The present study demonstrated that the proteomics of living organisms contains natural compounds that can be considered a valuable source of medically important resources.
- 5 November 2022
- Published by Maad Rayan Publishing Company in Avicenna Journal of Medical Biochemistry
- Vol. 10 (2) , 148-152
A Flippase-Like Domain-Containing Protein From Deltaproteobacteria Bacterium (Marine Sediment Metagenome) Has Anti-prostate Cancer Effects
Background: Prostate cancer is the second prevalent cancer and the fifth cause of deaths related to the men malignancies. The cancerous cell can travel from prostate to other parts of the body and cause metastasis in other organs such as bones and lymph nodes. For the treatment of the prostate cancer, chemotherapy and hormone therapy are being used. Hormone therapy in this disease is primarily based on the androgen suppression to prevent the growth and division of the cancerous cells. Different classes of drugs are used for hormone therapy. One group of these drugs is reducers of androgen production in adrenal glands. These drugs prevent the androgen production in adrenal glands and cancerous cells. Leuprorelin which is also known as leuprolide is a synthetic peptide that is used for treatment of prostate cancer. Objectives: The aim of this study is to explore novel anti-prostate cancer compounds using proteomics of microorganisms. Methods: Leuprorelin synthetic peptide was chosen as the template for amino acid sequence homology search using blast, and the resulting protein of the best candidate sequences were employed as a query to perform docking test against the gonadotropin-releasing hormone receptor (GRHR) using HDOCK web server. Results: By employing an in silico approach, natural products with structure and function similar to leuprorelin were explored, and their features were characterized. A flippase-like domain-containing protein from Deltaproteobacteria bacterium showed strong binding to gonadotropin-releasing hormone receptor GRHR with docking score of -425. The absorption, distribution, metabolism, and excretion (ADME) tests showed no potential toxicity of this natural product to the body. Conclusion: The present study demonstrated that the proteomics of living organisms contains natural compounds that can be considered a valuable source of medically important resources.
- 25 October 2022
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 23 (4) , 1107-1121
Recent advances in gene therapy: genetic bullets to the root of the problem
Genetics and molecular genetic techniques have changed many perspectives and paradigms in medicine. Using genetic methods, many diseases have been cured or alleviated. Gene therapy, in its simplest definition, is application of genetic materials and related techniques to treat various human diseases. Evaluation of the trends in the field of medicine and therapeutics clarifies that gene therapy has attracted a lot of attention due to its powerful potential to treat a number of diseases. There are various genetic materials that can be used in gene therapy such as DNA, single- and double-stranded RNA, siRNA and shRNA. The main gene editing techniques used for in vitro and in vivo gene modification are ZNF, TALEN and CRISPR-Cas9. The latter has increased hopes for more precise and efficient gene targeting as it requires two separate recognition sites which makes it more specific and can also cause rapid and sufficient cleavage within the target sequence. There must be carriers for delivering genes to the target tissue. The most commonly used carriers for this purpose are viral vectors such as adenoviruses, adeno-associated viruses and lentiviruses. Non-viral vectors consist of bacterial vectors, liposomes, dendrimers and nanoparticles. Graphical abstract
- 25 October 2022
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 23 (4) , 1107-1121
Recent advances in gene therapy: genetic bullets to the root of the problem
Genetics and molecular genetic techniques have changed many perspectives and paradigms in medicine. Using genetic methods, many diseases have been cured or alleviated. Gene therapy, in its simplest definition, is application of genetic materials and related techniques to treat various human diseases. Evaluation of the trends in the field of medicine and therapeutics clarifies that gene therapy has attracted a lot of attention due to its powerful potential to treat a number of diseases. There are various genetic materials that can be used in gene therapy such as DNA, single- and double-stranded RNA, siRNA and shRNA. The main gene editing techniques used for in vitro and in vivo gene modification are ZNF, TALEN and CRISPR-Cas9. The latter has increased hopes for more precise and efficient gene targeting as it requires two separate recognition sites which makes it more specific and can also cause rapid and sufficient cleavage within the target sequence. There must be carriers for delivering genes to the target tissue. The most commonly used carriers for this purpose are viral vectors such as adenoviruses, adeno-associated viruses and lentiviruses. Non-viral vectors consist of bacterial vectors, liposomes, dendrimers and nanoparticles. Graphical abstract
- 5 August 2022
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 119 (11) , 3007-3021
New horizons in developing cell lysis methods: A review
Cell lysis is an essential step in many studies related to biology and medicine. Based on the scale and medium that cell lysis is carried out, there are three main types of the cell lysis: (1) lysis of the cells in the surrounding environment, (2) lysis of the isolated or cultured cells, and (3) single cell lysis. Conventionally, several cell lysis methods have been developed, such as freeze‐thawing, bead beating, incursion in liquid nitrogen, sonication, and enzymatic and chemical‐based approaches. In recent years, various novel technologies have been employed to develop new methods of cell lysis. The aim of studies in this field is to introduce more precise and efficient tools or to reduce the costs of cell lysis procedures. Nanostructure‐based lysis methods, acoustic oscillation, electrical current, irradiation, bacteria‐mediated cell lysis, magnetic ionic liquids, bacteriophage genes, monolith columns, hydraulic forces, and steam explosion are some examples of newly developed cell lysis methods. Besides the significant advances in this field, there are still many challenges and tools must be further improved.
- 5 August 2022
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 119 (11) , 3007-3021
New horizons in developing cell lysis methods: A review
Cell lysis is an essential step in many studies related to biology and medicine. Based on the scale and medium that cell lysis is carried out, there are three main types of the cell lysis: (1) lysis of the cells in the surrounding environment, (2) lysis of the isolated or cultured cells, and (3) single cell lysis. Conventionally, several cell lysis methods have been developed, such as freeze‐thawing, bead beating, incursion in liquid nitrogen, sonication, and enzymatic and chemical‐based approaches. In recent years, various novel technologies have been employed to develop new methods of cell lysis. The aim of studies in this field is to introduce more precise and efficient tools or to reduce the costs of cell lysis procedures. Nanostructure‐based lysis methods, acoustic oscillation, electrical current, irradiation, bacteria‐mediated cell lysis, magnetic ionic liquids, bacteriophage genes, monolith columns, hydraulic forces, and steam explosion are some examples of newly developed cell lysis methods. Besides the significant advances in this field, there are still many challenges and tools must be further improved.